Skip to main content
Erschienen in: Pediatric and Developmental Pathology 4/2004

01.04.2004 | Case report

Sclerosing Rhabdomyosarcoma in Childhood: Case Report and Review of the Literature

verfasst von: Bhumita Vadgama, Neil James Sebire, Marian Malone, Alan Drummond Ramsay

Erschienen in: Pediatric and Developmental Pathology | Ausgabe 4/2004

Einloggen, um Zugang zu erhalten

Abstract

Rhabdomyosarcoma is the most common soft tissue malignancy in children but is rare in adults. The latest World Health Organization classification of soft tissue tumors recognizes embryonal, alveolar, and pleomorphic rhabdomyosarcomas. More recently, a sclerosing variant of rhabdomyosarcoma has been recognized and reported in seven adult patients. We describe a pediatric case of sclerosing rhabdomyosarcoma presenting as a sacral mass in a 3-year-old girl. Morphologically, the tumor showed a prominent sclerosing hyaline matrix and demonstrated pseudovascular and microalveolar architectural foci. Focal positivity was seen with desmin, smooth muscle actin, and myogenin. MyoD1 showed uniform diffuse nuclear staining. Fusion transcripts were not demonstrated by reverse transcriptase-polymerase chain reaction analysis. The histology, immunohistochemistry, and molecular genetics matched those reported in the seven adult cases of sclerosing rhabdomyosarcoma. This is the first case report, to our knowledge, of this rare tumor arising in the pediatric age group, and we compare the features with those reported in adult sclerosing rhabdomyosarcoma.
Literatur
1.
Zurück zum Zitat Parham, DM 2001Pathologic classification of rhabdomyosarcomas and correlations with molecular studiesMod Pathol14506514CrossRefPubMed Parham, DM 2001Pathologic classification of rhabdomyosarcomas and correlations with molecular studiesMod Pathol14506514CrossRefPubMed
2.
Zurück zum Zitat Mentzel, T, Katenkamp, D 2000Sclerosing, pseudovascular rhabdomyosarcoma in adults; clinicopathological and immunohistochemical analysis of three casesVirchows Arch436305311CrossRefPubMed Mentzel, T, Katenkamp, D 2000Sclerosing, pseudovascular rhabdomyosarcoma in adults; clinicopathological and immunohistochemical analysis of three casesVirchows Arch436305311CrossRefPubMed
3.
Zurück zum Zitat Folpe, AL, McKenney, JK, Bridge, JA, Weiss, SW 2002Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcomaAm J Surg Pathol2611751183CrossRefPubMed Folpe, AL, McKenney, JK, Bridge, JA, Weiss, SW 2002Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcomaAm J Surg Pathol2611751183CrossRefPubMed
5.
Zurück zum Zitat Qualman, SJ, Coffin, CM, Newton, WA, et al. 1998Intergroup Rhabdomyosarcoma Study: update for pathologistsPediatr Dev Pathol1550561CrossRefPubMed Qualman, SJ, Coffin, CM, Newton, WA,  et al. 1998Intergroup Rhabdomyosarcoma Study: update for pathologistsPediatr Dev Pathol1550561CrossRefPubMed
6.
Zurück zum Zitat Newton, WA,Jr, Gehan, EA, Webber, BL, et al. 1995Classification of rhabdomyosarcoma and related sarcomas: pathologic aspect and proposal for a new classification—an Intergroup Rhabdomyosarcoma StudyCancer7610731085PubMed Newton, WA,Jr, Gehan, EA, Webber, BL,  et al. 1995Classification of rhabdomyosarcoma and related sarcomas: pathologic aspect and proposal for a new classification—an Intergroup Rhabdomyosarcoma StudyCancer7610731085PubMed
7.
Zurück zum Zitat Chiles M, Parham D, Qualman S, et al. Pediatric matrix-rich rhabdomyosarcomas (Abstract). Pediatr Dev Pathol 2002;5:606. Chiles M, Parham D, Qualman S, et al. Pediatric matrix-rich rhabdomyosarcomas (Abstract). Pediatr Dev Pathol 2002;5:606.
8.
Zurück zum Zitat Boué, D, Parham, D, Teot, L, Crist, WM, Qualman, SJ 2000Clinicopathologic study of pediatric ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Group III and IVPediatr Dev Pathol3290300CrossRefPubMed Boué, D, Parham, D, Teot, L, Crist, WM, Qualman, SJ 2000Clinicopathologic study of pediatric ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Group III and IVPediatr Dev Pathol3290300CrossRefPubMed
9.
Zurück zum Zitat Sebire, NJ, Malone, M 2003Myogenin and MyoD1 expression in paediatric rhabdomyosarcomasJ Clin Pathol56412416CrossRefPubMed Sebire, NJ, Malone, M 2003Myogenin and MyoD1 expression in paediatric rhabdomyosarcomasJ Clin Pathol56412416CrossRefPubMed
10.
Zurück zum Zitat Sorensen, PHB, Lynch, JC, Qualman, SJ, et al. 2002PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology GroupJ Clin Oncol2026722679CrossRefPubMed Sorensen, PHB, Lynch, JC, Qualman, SJ,  et al. 2002PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology GroupJ Clin Oncol2026722679CrossRefPubMed
11.
Zurück zum Zitat Parham, DM, Barr, FG 2002Embryonal rhabdomyosarcomaFletcher, CDMUnni, KKMertens, F eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and BoneIARC PressLyon, France146149 Parham, DM, Barr, FG 2002Embryonal rhabdomyosarcomaFletcher, CDMUnni, KKMertens, F eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and BoneIARC PressLyon, France146149
12.
Zurück zum Zitat Dias, P, Chen, B, Dilday, B, et al. 2000Strong immuostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclassAm J Surg Pathol156399408 Dias, P, Chen, B, Dilday, B,  et al. 2000Strong immuostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclassAm J Surg Pathol156399408
13.
Zurück zum Zitat Cui, S, Hano, H, Harada, T, Takai, S, Masui, F, Ushigome, S 1999Evaluation of the new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcomaPathol Int496268CrossRefPubMed Cui, S, Hano, H, Harada, T, Takai, S, Masui, F, Ushigome, S 1999Evaluation of the new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcomaPathol Int496268CrossRefPubMed
14.
Zurück zum Zitat Williams, S, Sebire, NJ, Ramsay, A 2002Immunohistochemical expression of myogenin and MyoD1 in embryonal, classic alveolar and solid-variant paediatric alveolar rhabdomyosarcoma (Abstract)J Pathol19825A Williams, S, Sebire, NJ, Ramsay, A 2002Immunohistochemical expression of myogenin and MyoD1 in embryonal, classic alveolar and solid-variant paediatric alveolar rhabdomyosarcoma (Abstract)J Pathol19825A
15.
Zurück zum Zitat Barr, FG, Qualman, SJ, Macris, MH, et al. 2002Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusionsCancer Res6247044710PubMed Barr, FG, Qualman, SJ, Macris, MH,  et al. 2002Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusionsCancer Res6247044710PubMed
Metadaten
Titel
Sclerosing Rhabdomyosarcoma in Childhood: Case Report and Review of the Literature
verfasst von
Bhumita Vadgama
Neil James Sebire
Marian Malone
Alan Drummond Ramsay
Publikationsdatum
01.04.2004
Verlag
Springer-Verlag
Erschienen in
Pediatric and Developmental Pathology / Ausgabe 4/2004
Print ISSN: 1093-5266
Elektronische ISSN: 1615-5742
DOI
https://doi.org/10.1007/s10024-003-9453-5

Weitere Artikel der Ausgabe 4/2004

Pediatric and Developmental Pathology 4/2004 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …